Home> Products> biguanide therapy

{ "products": [ { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G 0.5 FORTE", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-07-24T12:57:55.385Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "glimepiride and metformin hydrochloride tablets", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6810aa8d5a26e4010ea41a99", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH MET", "description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "unusual tiredness", "medical advice", "monotherapy directions", "healthcare provider", "healthy diet", "chew continue", "meals swallow", "fat tissues", "dual mechanism", "hypoglycemia compared", "cardiovascular complications", "secondline treatment", "metformin dehydration", "insulin allowing", "bodys sensitivity", "kidneys reducing", "low risk", "diet exercise", "improving insulin sensitivity", "promoting glucose excretion", "reducing glucose production", "side effects risk", "biguanide class medication", "lowers blood glucose", "low blood pressure", "regular exercise routine", "metformin hydrochloride designed", "urinary tract infections", "dry mouth nausea", "blocking sglt2 proteins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2093, "imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png", "tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-29T10:31:41.504Z", "updatedon": "2025-04-29T10:32:46.171Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-met/2093", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (12.5mg) ,Metformin Hydrochloride (500mg)", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin 12.5 mg+metformin 1000 mg", "empagliflozin 12.5mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35ad2c50c07ee3dcaceda", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2047, "imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:34:26.615Z", "updatedon": "2025-03-22T10:19:44.132Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "category": "", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666050a6ea22b014e8af196f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP M 5/500 ", "description": "LINALIGLIP M 5/500 \nLinagliptin 5mg and Metformin Hydrochloride (SR) 500mg\nIntroduction to LINALIGLIP M 5/500\nLINALIGLIP M 5/500 is a combination medication that includes Linagliptin 5mg and Metformin Hydrochloride (Sustained Release) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP M 5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of LINALIGLIP M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP M 5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP M 5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is known to have a neutral or weight-reducing effect, making it beneficial for patients concerned about weight gain.\nCardiovascular Protection: The combination may offer additional cardiovascular benefits by improving overall metabolic health.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP M 5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-m-5-500-134301", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "liver", "meals", "water", "amount", "action", "neutral", "Support", "Overview", "patients", "one pill", "readings", "biguanide", "Guidelines", "full glass", "one tablet", "neuropathy", "Optimal Use", "utilization", "retinopathy", "Convenience", "Adjustments", "information", "weight gain", "Introduction", "Reduced Risk", "best results", "sterispharma", "Postprandial", "sterisonline", "CALL/WHATSAPP", "effectiveness", "typical dosage", "dual mechanism", "Administration", "treatment plan", "Consistent Use", "insulin release", "Linagliptin 5mg", "glucagon levels", "two medications", "prolonged effect", "Exercise Adjunct", "incretin hormones", "Weight Management", "Sustained Release", "treatment regimen", "excellent adjunct", "multiple pathways", "LINALIGLIP M 5/500", "glucose regulation", "patient compliance", "Twice-Daily Dosing", "Recommended Dosage", "prescribed therapy", "individual response", "insulin sensitivity", "Reduced Pill Burden", "Diabetes Management", "healthcare provider", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "weight-reducing effect", "Fasting Glucose Control", "lifestyle modifications", "Metformin Hydrochloride", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "Cardiovascular Protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "overall blood sugar control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "additional cardiovascular benefits", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1384, "imageuri": "https://productimages.withfloats.com/actual/666050a84f159c14e162c5d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/666050a84f159c14e162c5d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:48:54.497Z", "updatedon": "2024-06-29T11:16:30.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-m-5-500-/1384", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP M 5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP M 5/500", "Linagliptin 5mg", "Metformin Hydrochloride (SR) 500mg", "Metformin hydrochloride SR 500 mg uses", "Metformin SR 500 side effects", "Metformin SR 500 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604fa8870e7b20c49e43ef", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5/500 ", "description": "LINALIGLIP 2.5/500 \nLinagliptin & Metformin Hydrochloride\nIntroduction to LINALIGLIP 2.5/500\nLINALIGLIP 2.5/500 is a combination medication that includes Linagliptin 2.5mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP 2.5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of LINALIGLIP 2.5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The formulation allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP 2.5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-500-134273", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "water", "liver", "EMAIL", "meals", "Order", "action", "amount", "therapy", "Support", "readings", "Benefits", "Overview", "one pill", "patients", "biguanide", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "Convenience", "formulation", "Adjustments", "Linagliptin", "information", "Optimal Use", "utilization", "Reduced Risk", "best results", "sterisonline", "Introduction", "Postprandial", "sterispharma", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "treatment plan", "dual mechanism", "glucagon levels", "two medications", "insulin release", "Exercise Adjunct", "treatment regimen", "multiple pathways", "excellent adjunct", "incretin hormones", "patient compliance", "LINALIGLIP 2.5/500", "glucose regulation", "Twice-Daily Dosing", "Recommended Dosage", "Diabetes Management", "healthcare provider", "Reduced Pill Burden", "individual response", "insulin sensitivity", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Metformin Hydrochloride", "Fasting Glucose Control", "complementary mechanisms", "type 2 diabetes mellitus", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "overall blood sugar control", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1382, "imageuri": "https://productimages.withfloats.com/actual/66604fab4f159c14e162bd89.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604fab4f159c14e162bd89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:44:40.743Z", "updatedon": "2024-06-29T11:20:20.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-2-5-500-/1382", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5/500", "Linagliptin", "Metformin Hydrochloride", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride used for", "metformin hydrochloride dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6660456866170d1ff8cb29b0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN M KIT ", "description": "GLISITAPTIN M KIT \nCombipack of sitagliptin phosphate (100mg) & Metformin HCI SR (1000mg)\nIntroduction to GLISITAPTIN M KIT\nGLISITAPTIN M KIT is a combination pack that includes Sitagliptin Phosphate 100mg and Metformin HCl SR 1000mg. This combipack is designed for the comprehensive management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, GLISITAPTIN M KIT provides effective glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of GLISITAPTIN M KIT\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Sitagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN M KIT is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance.\nReduced Pill Burden: Combining two effective diabetes medications into a single combipack simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISITAPTIN M KIT\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN M KIT is one tablet of Sitagliptin 100mg taken once daily and one tablet of Metformin HCl SR 1000mg taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablets with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablets whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN M KIT regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-m-kit-133870", "price": 555.0, "discountamount": 166.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "liver", "water", "amount", "action", "Support", "tablets", "patients", "Overview", "Benefits", "readings", "biguanide", "neuropathy", "one tablet", "Guidelines", "full glass", "retinopathy", "information", "Optimal Use", "Convenience", "utilization", "Adjustments", "best results", "Postprandial", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "blood glucose", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "dual mechanism", "treatment plan", "glucagon levels", "two medications", "insulin release", "Metformin HCl SR", "Metformin HCI SR", "Exercise Adjunct", "prolonged effect", "combination pack", "single combipack", "Sitagliptin 100mg", "multiple pathways", "excellent adjunct", "GLISITAPTIN M KIT", "treatment regimen", "glucose regulation", "Twice-Daily Dosing", "patient compliance", "Recommended Dosage", "prescribed therapy", "Reduced Pill Burden", "insulin sensitivity", "individual response", "healthcare provider", "Diabetes Management", "meal) glucose levels", "sitagliptin phosphate", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "comprehensive management", "type 2 diabetes mellitus", "complementary mechanisms", "natural incretin hormones", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "effective glycemic control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1373, "imageuri": "https://productimages.withfloats.com/actual/6660456a9a0a3c2c06ff4c20.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660456a9a0a3c2c06ff4c20.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:00:56.265Z", "updatedon": "2024-06-29T12:05:00.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisitaptin-m-kit-/1373", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN M KIT ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN M KIT", "Combipack of sitagliptin phosphate (100mg)", "Metformin HCI SR (1000mg)", "Metformin SR 1000 mg uses", "Metformin SR 1000 mg side effects", "Metformin SR 1000 Mg Uses in Hindi", "Metformin SR 1000 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666043864515df1748620999", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN M 50/500 ", "description": "GLISITAPTIN M 50/500 \nSitagliptin Phosphate (50mg) & Metformin HCI (500mg)\nIntroduction to GLISITAPTIN M 50/500\nGLISITAPTIN M 50/500 is a combination medication containing Sitagliptin Phosphate 50mg and Metformin HCl 500mg. This medication is used primarily for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, GLISITAPTIN M 50/500 offers comprehensive glycemic control, helping patients achieve better blood sugar management and overall metabolic health.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of GLISITAPTIN M 50/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Sitagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN M 50/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The formulation allows for twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISITAPTIN M 50/500\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN M 50/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN M 50/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-m-50-500-133906", "price": 415.0, "discountamount": 124.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "EMAIL", "liver", "water", "Order", "meals", "action", "amount", "Support", "Benefits", "one pill", "readings", "Overview", "patients", "biguanide", "neuropathy", "Guidelines", "full glass", "one tablet", "utilization", "retinopathy", "Optimal Use", "Convenience", "information", "Adjustments", "formulation", "sterisonline", "Postprandial", "sterispharma", "Reduced Risk", "Introduction", "best results", "Metformin HCI", "GLISITAPTIN M", "blood glucose", "effectiveness", "CALL/WHATSAPP", "Metformin HCl", "dual mechanism", "Administration", "typical dosage", "treatment plan", "Consistent Use", "two medications", "insulin release", "glucagon levels", "Exercise Adjunct", "multiple pathways", "excellent adjunct", "treatment regimen", "prescribed therapy", "glucose regulation", "patient compliance", "Recommended Dosage", "Twice-Daily Dosing", "Diabetes Management", "insulin sensitivity", "healthcare provider", "blood sugar control", "individual response", "Reduced Pill Burden", "meal) glucose levels", "Sitagliptin Phosphate", "combination medication", "cardiovascular disease", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "peripheral glucose uptake", "natural incretin hormones", "stable blood sugar levels", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1371, "imageuri": "https://productimages.withfloats.com/actual/666043889917812fea56f4fa.png", "tileimageuri": "https://productimages.withfloats.com/tile/666043889917812fea56f4fa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:52:54.03Z", "updatedon": "2024-06-29T12:11:59.747Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisitaptin-m-50-500-/1371", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN M 50/500 ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN M 50/500", "Sitagliptin Phosphate (50mg)", "Metformin HCI (500mg)", "Sitagliptin 50 mg price", "Sitagliptin phosphate-metformin hydrochloride tabl", "Sitagliptin side effects", "Sitagliptin 100 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666042368e599e12c0ea94ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN M 1000 ", "description": "GLISITAPTIN M 1000 \nSitagliptin Phosphate (50mg), Metformin HCI (1000mg)\nIntroduction to GLISITAPTIN M 1000\nGLISITAPTIN M 1000 is a combination medication containing Sitagliptin Phosphate 50mg and Metformin HCl 1000mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, GLISITAPTIN M 1000 offers comprehensive glycemic control, helping patients achieve better blood sugar management and overall metabolic health.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of GLISITAPTIN M 1000\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Sitagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN M 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The formulation allows for twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISITAPTIN M 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN M 1000 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN M 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-m-1000-133869", "price": 525.0, "discountamount": 157.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "EMAIL", "liver", "water", "Order", "meals", "action", "amount", "Support", "Benefits", "one pill", "readings", "Overview", "patients", "biguanide", "neuropathy", "Guidelines", "full glass", "one tablet", "utilization", "retinopathy", "Optimal Use", "Convenience", "information", "Adjustments", "formulation", "sterisonline", "Postprandial", "sterispharma", "Reduced Risk", "Introduction", "best results", "Metformin HCI", "GLISITAPTIN M", "blood glucose", "effectiveness", "CALL/WHATSAPP", "Metformin HCl", "dual mechanism", "Administration", "typical dosage", "treatment plan", "Consistent Use", "two medications", "insulin release", "glucagon levels", "Exercise Adjunct", "multiple pathways", "excellent adjunct", "treatment regimen", "prescribed therapy", "glucose regulation", "patient compliance", "Recommended Dosage", "Twice-Daily Dosing", "Diabetes Management", "insulin sensitivity", "healthcare provider", "blood sugar control", "individual response", "Reduced Pill Burden", "meal) glucose levels", "Sitagliptin Phosphate", "combination medication", "cardiovascular disease", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "peripheral glucose uptake", "natural incretin hormones", "stable blood sugar levels", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1370, "imageuri": "https://productimages.withfloats.com/actual/6660423b4b2b24fcd89b7afb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660423b4b2b24fcd89b7afb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:47:18.95Z", "updatedon": "2024-06-29T12:13:12.761Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glisitaptin-m-1000-/1370", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN M 1000 ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN M 1000", "Sitagliptin Phosphate (50mg)", "Metformin HCI (1000mg)", "Sitagliptin 50 mg price", "Sitagliptin phosphate-metformin hydrochloride tabl", "Sitagliptin side effects", "Sitagliptin 100 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }